Stay updated on Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUpdates to the trial record’s maintenance fields include revised last update/post information and the site revision version, along with corresponding changes to previously shown dates. These reflect administrative/versioning changes rather than substantive study details.SummaryDifference0.3%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.0 appears on the page, replacing the previous v3.4.3.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.3 replaces the prior v3.4.2. This appears to be an internal version update with no visible changes to the page’s study details or user-facing content.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now displays Revision: v3.4.2 and removes the older funding/operating status notice, which are maintenance updates with no impact on study information or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operating status has been added, and the page version has been updated to Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.